Masimo Corporation MASI recently announced Sleep Halo, a powerful new feature, for its Masimo W1 Sport advanced health tracking wearable, intended for scientifically based sleep analysis.

Masimo announced Dual SET® Pulse Oximetry with the CE marking and launch of the SET® Module and Eve™ CCHD Newborn Screening Application for Root®.

Provided by Business WireAug 26, 2024 12:00pm Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact Masimo SET® Is the Primary Pulse Oximetry at All 10 Top U ...

IRVINE, Calif. , May 19, 2011 /PRNewswire/ — Masimo (NASDAQ: MASI) announced today the launch of its new sub-45 milliwatt technology platform—MS-2040. This platform utilizes nearly a third of the ...

In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry’s ability to ...

Medical grade pulse oximetry devices are what Masimo specializes in, and pulse oximetry is a feature that Apple added to the Apple Watch with the Series 6 model.

More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their patient monitoring technologies.

Apple infringed on one of medical technology company Masimo's pulse oximeter patents when it launched Apple Watch models that use light sensors ...

Notable Developments In August 2020, Masimo announced a favorable result from its study in the field of pulse oximetry technologies.

Masimo today announced that the largest-ever study of newborn screening for congenital heart disease was published online by The Lancet. The study of 122,738 newborns -- more than twice as large ...

IRVINE, Calif. , Jan. 9, 2012 /PRNewswire/ — Masimo (NASDAQ: MASI) today announced FDA 510 (k) clearance and full market commercial launch of the Masimo Pronto-7®—a palm-sized handheld device designed ...